Veterinary Medicines

Biocom P Vet

Authorised
  • Clostridium botulinum, type C, toxoid
  • Pseudomonas aeruginosa, serotype 5, strain PA5G-485, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JA, Inactivated
  • Mink enteritis virus, type 1, strain United, Inactivated
  • Pseudomonas aeruginosa, serotype 5, strain PA5M-485-P, Inactivated
  • Pseudomonas aeruginosa, serotype 7/8, strain PA7G-485, Inactivated
  • Mink enteritis virus, type 2, strain Ithaca, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6G-485, Inactivated
  • Pseudomonas aeruginosa, serotype 7, strain PA7M-485-347, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JB, Inactivated
Download as PDF

Product identification

Medicine name:
Biocom P Vet
BIOCOM P VET SUSPENSION INYECTABLE PARA VISONES
Active substance:
  • Clostridium botulinum, type C, toxoid
  • Pseudomonas aeruginosa, serotype 5, strain PA5G-485, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JA, Inactivated
  • Mink enteritis virus, type 1, strain United, Inactivated
  • Pseudomonas aeruginosa, serotype 5, strain PA5M-485-P, Inactivated
  • Pseudomonas aeruginosa, serotype 7/8, strain PA7G-485, Inactivated
  • Mink enteritis virus, type 2, strain Ithaca, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6G-485, Inactivated
  • Pseudomonas aeruginosa, serotype 7, strain PA7M-485-347, Inactivated
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JB, Inactivated
Target species:
  • Mink
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium botulinum, type C, toxoid
    40.00
    80% Protective Dose
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 5, strain PA5G-485, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JA, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Mink enteritis virus, type 1, strain United, Inactivated
    1.00
    80% Protective Dose
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 5, strain PA5M-485-P, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 7/8, strain PA7G-485, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Mink enteritis virus, type 2, strain Ithaca, Inactivated
    1.00
    80% Protective Dose
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 6, strain PA6G-485, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 7, strain PA7M-485-347, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JB, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Mink
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI20CL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Polyethylene bottle containing 500 ml (500 doses), closed with a rubber stopper and sealed with an aluminum cap.
  • Polyethylene bottle containing 250 ml (250 doses), closed with a rubber stopper and sealed with an aluminum cap.
  • Polyethylene bottle containing 100 ml (100 doses), closed with a rubber stopper and sealed with an aluminum cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • United Vaccines Holding B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cooperative Federation Of Nobel Animal Keepers Nederasselt U.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 3603 ESP
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0227/001
Concerned member states:
  • Denmark
  • Finland
  • Greece
  • Italy
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Romania
  • Spain
  • Sweden

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 22/05/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 22/05/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 22/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."